Inscription Capital, LLC Merck & Co., Inc. Transaction History

Inscription Capital, LLC

$661 Million
Q3 2024

A detailed history of Inscription Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Inscription Capital, LLC holds 35,496 shares of MRK stock, worth $3.48 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

35,496

Previous 37,142 4.43%

Holding current value

$3.48 Million

Previous $4.6 Million 12.35%

% of portfolio

0.61%

Previous 0.75%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$111.15 - $128.97 $182,952 - $212,284	-1,646 Reduced 4.43%	35,496 $4.03 Million
Q2 2024 Jul 17, 2024	SELL	$123.8 - $132.96 $62,519 - $67,144	-505 Reduced 1.34%	37,142 $4.6 Million
Q1 2024 Jul 17, 2024	BUY	$113.24 - $131.95 $4.26 Million - $4.97 Million	37,647 New	37,647 $4.97 Million
Q4 2023 Jan 18, 2024	BUY	$100.18 - $109.02 $192,545 - $209,536	1,922 Added 6.65%	30,839 $3.36 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $5,147 - $5,716	-50 Reduced 0.17%	28,917 $2.98 Million
Q2 2023 Jul 14, 2023	SELL	$108.61 - $118.38 $83,412 - $90,915	-768 Reduced 2.58%	28,967 $3.34 Million
Q1 2023 May 02, 2023	BUY	$102.94 - $114.86 $10,602 - $11,830	103 Added 0.35%	29,735 $3.16 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $17,925 - $22,982	-205 Reduced 0.69%	29,632 $3.29 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $11.6 Million - $13 Million	-137,405 Reduced 82.16%	29,837 $2.57 Million
Q2 2022 Sep 20, 2022	BUY	$83.49 - $94.64 $11.4 Million - $12.9 Million	136,760 Added 448.66%	167,242 $15.2 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $124,967 - $140,080	-1,700 Reduced 5.28%	30,482 $2.52 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $188,000 - $235,494	2,601 Added 8.79%	32,182 $2.49 Million
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $3.81 Million - $4.19 Million	-53,170 Reduced 64.25%	29,581 $2.24 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $3.8 Million - $4.2 Million	54,067 Added 188.49%	82,751 $6.44 Million
Q1 2021 May 18, 2021	SELL	$68.86 - $81.11 $206,993 - $243,816	-3,006 Reduced 9.49%	28,684 $2.23 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $142,965 - $158,662	1,992 Added 6.71%	31,690 $2.61 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $34,906 - $39,567	-477 Reduced 1.58%	29,698 $2.48 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $236,611 - $269,236	3,360 Added 12.53%	30,175 $2.35 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $28,448 - $39,431	-449 Reduced 1.65%	26,815 $2.08 Million
Q4 2019 Feb 04, 2020	BUY	$77.58 - $87.54 $560,825 - $632,826	7,229 Added 36.08%	27,264 $2.5 Million
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $1.52 Million - $1.66 Million	20,035 New	20,035 $1.7 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $59,433 - $69,433	-851 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$69.58 - $79.36 $35,833 - $40,870	-515 Reduced 37.7%	851 $71,000
Q4 2018 May 16, 2019	BUY	$65.24 - $75.71 $89,117 - $103,419	1,366 New	1,366 $105,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.

Account

Inscription Capital, LLC Merck & Co., Inc. Transaction History